Abstract
Clostridium indolis is an anaerobic spore-forming Gram-positive bacillus belonging to the Clostridium saccharolyticum group. Its clinical significance in human remains poorly known. We describe the first case of osteitis related to C. indolis, identified by MALDI-TOF mass spectrometry and provide a literature review of human infections related to C. saccharolyticum group species.
Keywords:
Clostridium; Emerging pathogen; Osteitis.
Copyright © 2016 Elsevier Ltd. All rights reserved.
MeSH terms
-
Adult
-
Anaerobiosis
-
Anti-Bacterial Agents / therapeutic use
-
Bacterial Proteins / genetics*
-
Bacterial Proteins / metabolism
-
Chronic Disease
-
Clostridium / classification
-
Clostridium / drug effects
-
Clostridium / genetics
-
Clostridium / isolation & purification*
-
Clostridium Infections / diagnosis*
-
Clostridium Infections / drug therapy
-
Clostridium Infections / etiology
-
Clostridium Infections / microbiology
-
Enzyme Assays
-
Female
-
Fractures, Bone / complications
-
Fractures, Bone / diagnosis
-
Fractures, Bone / microbiology
-
Gene Expression
-
Humans
-
Microbial Sensitivity Tests
-
Osteitis / diagnosis*
-
Osteitis / drug therapy
-
Osteitis / etiology
-
Osteitis / microbiology
-
Phylogeny
-
RNA, Ribosomal, 16S / genetics*
-
RNA, Ribosomal, 16S / metabolism
-
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
RNA, Ribosomal, 16S